T‐cell subsets in the skin and their role in inflammatory skin disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T‐cell subsets in the skin and their role in inflammatory skin disorders
Authors
Keywords
-
Journal
ALLERGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-25
DOI
10.1111/all.15104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy
- (2021) Yongpeng Ge et al. CLINICAL RHEUMATOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The emerging role of autoreactive antibodies in inflammatory skin diseases
- (2021) I. Kortekaas Krohn JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Biologics for the Use in Chronic Spontaneous Urticaria: When and Which
- (2021) Marcus Maurer et al. Journal of Allergy and Clinical Immunology-In Practice
- High‐dimensional analysis defines multicytokine T‐cell subsets and supports a role for IL‐21 in atopic dermatitis
- (2021) Tali Czarnowicki et al. ALLERGY
- Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells
- (2021) Michael Delacher et al. IMMUNITY
- Presence and the roles of IL‐9/Th9 axis in vitiligo
- (2021) Sushant Kumar et al. Pigment Cell & Melanoma Research
- Nociceptive sensory neurons promote CD8 T cell responses to HSV-1 infection
- (2021) Jessica Filtjens et al. Nature Communications
- Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
- (2021) Sara De Biasi et al. Nature Communications
- Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders
- (2021) Jonathan I. Silverberg et al. JAMA Dermatology
- Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders
- (2021) Dario Didona et al. Frontiers in Immunology
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- (2021) Zhenpeng Dai et al. JCI Insight
- Autoreactive T cells and their role in atopic dermatitis
- (2021) Tina De Bruyn Carlier et al. JOURNAL OF AUTOIMMUNITY
- The antigen‐binding moiety in the driver's seat of CARs
- (2021) Heleen Hanssens et al. MEDICINAL RESEARCH REVIEWS
- Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials
- (2020) E.L. Simpson et al. BRITISH JOURNAL OF DERMATOLOGY
- Predominance of central memory T cells with high T-cell receptor repertoire diversity is associated with response to PD-1/PD-L1 inhibition in Merkel cell carcinoma
- (2020) Ivelina Spassova et al. CLINICAL CANCER RESEARCH
- Treatment of severe lichen planus with the JAK inhibitor tofacitinib
- (2020) William Damsky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Type 2 immunity in the skin and lungs
- (2020) Cezmi A. Akdis et al. ALLERGY
- Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticaria
- (2020) DA Sabag et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity
- (2020) Anne-Laure Flamar et al. IMMUNITY
- Phase 2 Randomized, Double-blind Study of IL-17-Targeting with Secukinumab in Atopic Dermatitis
- (2020) Benjamin Ungar et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Stage related PD‐L1 expression in Kaposi sarcoma tumor microenvironment
- (2020) Beatrice Joest et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age
- (2020) Koichi Yamaguchi et al. Modern Rheumatology
- Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial
- (2020) Masataka Kuwana et al. Modern Rheumatology
- Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development
- (2020) Shira Tabachnick-Cherny et al. MOLECULAR CARCINOGENESIS
- Lack of CD8+ T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors
- (2020) Salum J. Lidenge et al. Oncotarget
- Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
- (2020) Lichen Jing et al. Cancer Immunology Research
- Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers
- (2020) Daphne S. Bakker et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2020) Eric L Simpson et al. LANCET
- Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
- (2020) David Rosmarin et al. LANCET
- Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
- (2020) Kenji Kabashima et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
- (2020) Jonathan I. Silverberg et al. JAMA Dermatology
- IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis
- (2020) Fariza Mishaal Saiema Badloe et al. Clinical and Translational Allergy
- Systemic treatments in the management of atopic dermatitis: a systematic review and meta‐analysis
- (2020) Doreen Siegels et al. ALLERGY
- Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial
- (2020) J.I. Silverberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
- (2020) Bonnie S. Glisson et al. CLINICAL CANCER RESEARCH
- The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
- (2020) Niels Schaft Cancers
- IgE autoantibodies in serum and skin of non‐bullous and bullous pemphigoid patients
- (2020) A. Lamberts et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma
- (2019) Imelda Seminerio et al. Cancers
- Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid
- (2019) Eric H. Kowalski et al. AUTOIMMUNITY REVIEWS
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
- (2019) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL‐13
- (2019) Kazunari Sugita et al. ALLERGY
- Evidence for the induction of Th2 inflammation by group 2 innate lymphoid cells in response to prostaglandin D 2 and cysteinyl leukotrienes in allergic rhinitis
- (2019) Ichiro Tojima et al. ALLERGY
- Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis
- (2019) Thomas Bieber ALLERGY
- Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
- (2019) Lieneke F. M. Ariëns et al. ALLERGY
- Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ligelizumab for Chronic Spontaneous Urticaria
- (2019) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Th9 Cells Represent a Unique Subset of CD4 + T Cells Endowed with the Ability to Eradicate Advanced Tumors
- (2018) Yong Lu et al. CANCER CELL
- Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
- (2018) Neil H. Segal et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic drug evaluation of talimogene laherparepvec for the treatment of advanced melanoma
- (2018) Erin E. Burke et al. Expert Opinion on Drug Metabolism & Toxicology
- Histamine and T helper cytokine–driven epithelial barrier dysfunction in allergic rhinitis
- (2018) Brecht Steelant et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
- (2018) Andreas Wollenberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
- (2018) Heng Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
- (2018) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Intravital mucosal imaging of CD8+ resident memory T cells shows tissue-autonomous recall responses that amplify secondary memory
- (2018) Lalit K. Beura et al. NATURE IMMUNOLOGY
- Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo
- (2018) Jillian M. Richmond et al. Science Translational Medicine
- Atopic dermatitis
- (2018) Stephan Weidinger et al. Nature Reviews Disease Primers
- Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
- (2018) Kenneth B Gordon et al. LANCET
- Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Melanoma: A Single-Institution Experience
- (2018) Matthew C. Perez et al. ANNALS OF SURGICAL ONCOLOGY
- Role of non-classical T cells in skin immunity
- (2018) Joon Seok Park et al. MOLECULAR IMMUNOLOGY
- Thyroid Autoimmunity and Autoimmunity in Chronic Spontaneous Urticaria Linked to Disease Severity, Therapeutic Response, and Time to Remission in Patients with Chronic Spontaneous Urticaria
- (2018) Kumutnart Chanprapaph et al. Biomed Research International
- CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human Skin
- (2017) Stanley Cheuk et al. IMMUNITY
- Staged development of long-lived T-cell receptor αβ T H 17 resident memory T-cell population to Candida albicans after skin infection
- (2017) Chang Ook Park et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria
- (2017) Oliver Schmetzer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors
- (2017) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vitiligo-like lesions occurring in patients receiving anti-programmed cell death–1 therapies are clinically and biologically distinct from vitiligo
- (2017) Maiana Larsabal et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Different expression patterns of plasma Th1-, Th2-, Th17- and Th22-related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria
- (2017) Q. Chen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism
- (2017) Youdong Pan et al. NATURE
- Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
- (2017) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Helper Cell Differentiation, Heterogeneity, and Plasticity
- (2017) Jinfang Zhu Cold Spring Harbor Perspectives in Biology
- Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites
- (2017) Brahma V. Kumar et al. Cell Reports
- Circulating CLA+ T cells in atopic dermatitis and their possible role as peripheral biomarkers
- (2016) T. Czarnowicki et al. ALLERGY
- Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
- (2016) Neil H. Segal et al. CLINICAL CANCER RESEARCH
- Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
- (2016) Kilian Wistuba-Hamprecht et al. EUROPEAN JOURNAL OF CANCER
- Human innate lymphoid cells
- (2016) Jenny Mjösberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
- (2016) Thomas Werfel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit
- (2016) Priscilla Auyeung et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cutting Edge: Regulatory T Cells Facilitate Cutaneous Wound Healing
- (2016) Audrey Nosbaum et al. JOURNAL OF IMMUNOLOGY
- Ipilimumab-induced acute generalized exanthematous pustulosis in a patient with metastatic melanoma
- (2016) Shelley J.E. Hwang et al. MELANOMA RESEARCH
- NK cells and type 1 innate lymphoid cells: partners in host defense
- (2016) Hergen Spits et al. NATURE IMMUNOLOGY
- Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
- (2016) Christoph S N Klose et al. NATURE IMMUNOLOGY
- PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
- (2016) Paul T. Nghiem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis
- (2016) Drew J. B. Kurtzman et al. JAMA Dermatology
- Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
- (2016) Camille Hua et al. JAMA Dermatology
- PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome
- (2016) Joseph M. Obeid et al. OncoImmunology
- Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial
- (2015) K. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria
- (2015) A.B. Kay et al. BRITISH JOURNAL OF DERMATOLOGY
- Biomarkers for atopic dermatitis
- (2015) Judith Thijs et al. Current Opinion in Allergy and Clinical Immunology
- T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate
- (2015) Laura K. Mackay et al. IMMUNITY
- The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
- (2015) Shinji Noda et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
- (2015) Hansje-Eva Teulings et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutting Edge: CD69 Interference with Sphingosine-1-Phosphate Receptor Function Regulates Peripheral T Cell Retention
- (2015) Laura K. Mackay et al. JOURNAL OF IMMUNOLOGY
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
- (2015) Christopher E M Griffiths et al. LANCET
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- The burgeoning family of unconventional T cells
- (2015) Dale I Godfrey et al. NATURE IMMUNOLOGY
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells
- (2015) Rei Watanabe et al. Science Translational Medicine
- Defining Th-cell subsets in a classical and tissue-specific manner: Examples from the skin
- (2014) Stefanie Eyerich et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Circulating level of CD4+ CD25+ FOXP3+ T cells in patients with chronic urticaria
- (2014) Saba Arshi et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
- (2014) Howard Sofen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Epidermal Th22 and Tc17 Cells Form a Localized Disease Memory in Clinically Healed Psoriasis
- (2014) S. Cheuk et al. JOURNAL OF IMMUNOLOGY
- Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR + ILC3 in Lesional Skin and Blood of Psoriasis Patients
- (2014) Marcel B.M. Teunissen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis
- (2014) Yoshiro Horai et al. Modern Rheumatology
- The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
- (2014) Frédérique Végran et al. NATURE IMMUNOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Skin-resident memory CD8+ T cells trigger a state of tissue-wide pathogen alert
- (2014) S. Ariotti et al. SCIENCE
- CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
- (2014) M. Rashighi et al. Science Translational Medicine
- How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
- (2014) Ole Audun Werner Haabeth et al. Frontiers in Immunology
- Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin
- (2013) B. Dyring-Andersen et al. BRITISH JOURNAL OF DERMATOLOGY
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Different Frequencies of Tc17/Tc1 and Th17/Th1 Cells in Chronic Spontaneous Urticaria
- (2013) Ana Lopes et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Significantly High Levels of Anti-dsDNA Immunoglobulin E in Sera and the Ability of dsDNA to Induce the Degranulation of Basophils from Chronic Urticaria Patients
- (2013) Yuko Hatada et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic T Lymphocytes to Tumor Beds
- (2013) T. Lanca et al. JOURNAL OF IMMUNOLOGY
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Sweet’s syndrome in a patient with metastatic melanoma after ipilimumab therapy
- (2013) Sofya Pintova et al. MELANOMA RESEARCH
- Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues
- (2013) Jochem H Bernink et al. NATURE IMMUNOLOGY
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Epidermis instructs skin homing receptor expression in human T cells
- (2012) M. L. McCully et al. BLOOD
- Distribution and Compartmentalization of Human Circulating and Tissue-Resident Memory T Cell Subsets
- (2012) Taheri Sathaliyawala et al. IMMUNITY
- Does “autoreactivity” play a role in atopic dermatitis?
- (2012) Ting Seng Tang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CD8+ T Cells in the Lesional Skin of Atopic Dermatitis and Psoriasis Patients Are an Important Source of IFN-γ, IL-13, IL-17, and IL-22
- (2012) DirkJan Hijnen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells
- (2012) Rahul Purwar et al. NATURE MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
- (2012) Adriana Cordova et al. PLoS One
- Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients
- (2012) R. A. Clark et al. Science Translational Medicine
- Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes
- (2012) Marco Donia et al. OncoImmunology
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Intra-Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial
- (2011) A. Ribas et al. CLINICAL CANCER RESEARCH
- Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161
- (2011) Jenny M Mjösberg et al. NATURE IMMUNOLOGY
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma
- (2010) Karl S Peggs et al. Expert Review of Anticancer Therapy
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial
- (2009) I. D. Davis et al. CLINICAL CANCER RESEARCH
- A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid
- (2009) Kelly A.N. Messingham et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Quantification and molecular characterization of regulatory T cells in connective tissue diseases
- (2008) Leontina Banica et al. AUTOIMMUNITY
- Tumor-specific Th17-polarized cells eradicate large established melanoma
- (2008) P. Muranski et al. BLOOD
- Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways
- (2008) K.E. Nograles et al. BRITISH JOURNAL OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search